Clinical Trial Update: MEN1703 (SEL24) in Participants With Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completed Phase 1/2 results for MEN1703 (SEL24) in participants with Acute Myeloid Leukemia. Results were posted on 2025-04-2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• MEN1703 (SEL24) (SEL24)

Snippet

Sponsor: Menarini Group | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-29